Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Endometrial cancer
Stage/Subtype:  stage II endometrial cancer
Trial Type:  Treatment
Results 1-8 of 8 for your search:
Start Over
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: Over 18
Trial IDs: ENGOT-EN2-DGCG/EORTC55102, NCI-2014-00983, 2010-023081-52, NCT01244789
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients with High-Risk Endometrial Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 08-03-060, NCI-2013-01224, 07-062, NCI-2012-00458, NCT01041027
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients with Recurrent Stage I, III, or IV Endometrial Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S15-01156, NCI-2016-01206, NCT02744898
Proton Beam Radiation Therapy in Treating Patients with Uterine and Cervical Cancer with Regional Lymph Node Metastases
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 10-269, NCI-2011-00894, NCT01600040
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Diagnostic, Treatment
Age: Any age
Trial IDs: CASE 9813, NCI-2013-01309, NCT01939028
Metformin Hydrochloride and Levonorgestrel-Releasing Intrauterine System in Treating Patients with Atypical Endometrial Hyperplasia or Endometrial Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1326, NCI-2014-00799, 12-0886, 13-3723, NCT02035787
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Pembrolizumab in Treating Patients with Ovarian, Endometrial, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: Pro00068544, NCI-2016-01139, NCT02728830
Start Over